Post-IPO Equity - Terns Pharmaceuticals - Dec 20, 2022 Funding Round Profile - Cointime

Bitcoin $79,397.69 +3.79%
Ethereum $3,190.65 +4.73%
BNB $633.99 +1.21%
Optimism $1.67 +2.21%
Arbitrum $0.64 +4.76%
Solana $205.15 +1.63%
Polygon $0.41 +4.76%
Cosmos $5.20 +8.99%
Avalanche $31.90 +7.74%

Bitcoin $79,397.69 +3.79%
Ethereum $3,190.65 +4.73%
BNB $633.99 +1.21%
Optimism $1.67 +2.21%
Arbitrum $0.64 +4.76%
Solana $205.15 +1.63%
Polygon $0.41 +4.76%
Cosmos $5.20 +8.99%
Avalanche $31.90 +7.74%

Terns Pharmaceuticals

company

Funding Round

Post-IPO Equity

Money Raised

$ 86.30M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion

Historical Financing

Announced Date	Round	Money Raised	Investors
Aug 12, 2022	Post-IPO Equity	$ 65M	Fairmount Funds Management,Venrock Healthcare Capital Partners	Detail
Oct 30, 2018	Series B	$ 80M	Decheng Capital,Lilly Asia Ventures,etc.	Detail
Jan 5, 2021	Series C	$ 87M	Deepfield,Eli Lilly,etc.	Detail
Apr 4, 2018	Series A	$ 30M	Lilly Asia Ventures	Detail
Feb 4, 2021	IPO	$ 127.50M		Detail